Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Levesque

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
EMBO Molecular Medicine|December 10, 2016
Activin promotes skin carcinogenesis by attraction and reprogramming of macrophagesMaria Antsiferova, Aleksandra Piwko-Czuchra, Michael Cangkrama, et al.
Nature Communications|December 31, 2024
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3<sup>+</sup> T<sub>reg</sub> populationStefan Wolf, Matiar Madanchi, Patrick Turko, et al.
Neuro-Oncology|May 28, 2026
Spatially-resolved single-cell imaging of melanoma brain metastases identifies localized immune patterns predictive of immune checkpoint blockade responseStefanos Voglis, Daniel Schulz, Nils Eling, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
The Journal of Investigative Dermatology|May 14, 2026
Evaluating T-Cell Clonality In Skin Using a Quantitative TRBC1-Clonality ScoreChristoph Iselin, Pacôme Prompsy, Yi-Chien Tsai, et al.
British Journal of Cancer|March 22, 2017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapyAdi Nosrati, Katy K Tsai, Simone M Goldinger, et al.
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
The Journal of Clinical Investigation|November 6, 2018
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activationAndrea Clocchiatti, Soumitra Ghosh, Maria-Giuseppina Procopio, et al.
Molecular Cell|May 22, 2026
In vivo single-cell ribosome profiling reveals cell-type-specific translational programs during agingClara Duré, Umesh Ghoshdastider, Ramona Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?Sara E Cerminara, Phil Cheng, Lisa Kostner, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
EMBO Molecular Medicine|December 10, 2016
Activin promotes skin carcinogenesis by attraction and reprogramming of macrophagesMaria Antsiferova, Aleksandra Piwko-Czuchra, Michael Cangkrama, et al.
Nature Communications|December 31, 2024
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3<sup>+</sup> T<sub>reg</sub> populationStefan Wolf, Matiar Madanchi, Patrick Turko, et al.
Neuro-Oncology|May 28, 2026
Spatially-resolved single-cell imaging of melanoma brain metastases identifies localized immune patterns predictive of immune checkpoint blockade responseStefanos Voglis, Daniel Schulz, Nils Eling, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
The Journal of Investigative Dermatology|May 14, 2026
Evaluating T-Cell Clonality In Skin Using a Quantitative TRBC1-Clonality ScoreChristoph Iselin, Pacôme Prompsy, Yi-Chien Tsai, et al.
British Journal of Cancer|March 22, 2017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapyAdi Nosrati, Katy K Tsai, Simone M Goldinger, et al.
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
The Journal of Clinical Investigation|November 6, 2018
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activationAndrea Clocchiatti, Soumitra Ghosh, Maria-Giuseppina Procopio, et al.
Molecular Cell|May 22, 2026
In vivo single-cell ribosome profiling reveals cell-type-specific translational programs during agingClara Duré, Umesh Ghoshdastider, Ramona Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?Sara E Cerminara, Phil Cheng, Lisa Kostner, et al.
Pageof 3